PMV Pharmaceuticals PMVP
NASDAQ PMVP
$1.26 +0.04 (+3.28%)
At close: Nov 11, 2026 · 4:00 PM EST

PMV Pharmaceuticals (PMVP) EBITDA Margin (2019 - 2026)

Updated

PMV Pharmaceuticals (PMVP) recorded EBITDA Margin of -2393.02% in Q2 2026, down 1041.13 percentage points from -1351.89% a year earlier and down 455.78 percentage points from the prior quarter.

Analysis

PMV Pharmaceuticals (PMVP) EBITDA Margin (2019 - 2026) Analysis & Trends

On a TTM basis, PMV Pharmaceuticals' EBITDA Margin came in at -1775.47% as of Jun 30, 2026, down 708.04 percentage points year-over-year; for FY2025, it came in at -1358.26%, down 567.05 percentage points from FY2024.

  • Annual EBITDA Margin has a five-year change of +3960.33 percentage points (FY2020 to FY2025).
  • Across earlier years, EBITDA Margin came in at -791.22% in FY2024 (-85.15 pp), -706.07% in FY2023 (+1409.32 pp), -2115.38% in FY2022 (+10799.09 pp) and -12914.48% in FY2021 (-7595.89 pp).
  • The Q2 2026 figure is the lowest quarterly EBITDA Margin since Q2 2022.
  • On a year-over-year basis, EBITDA Margin has declined for eight consecutive quarters, with an average year-over-year change of -608.22 percentage points over the last eight quarters.
  • Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 16180.32 percentage points in Q4 2022, against a drop of 1041.13 percentage points in Q2 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at -1937.24% (Q1 2026), -1559.17% (Q4 2025) and -1519.59% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 36.69%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 32.68%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 46.88%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 40.60%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 39.77%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 46.62%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 50.63%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 42.49%
10 PMV Pharmaceuticals 80.80 Mn -307.68 Mn - -2,414.46%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -2,414.46%
Jun 30, 2026 -2,393.02%
Mar 31, 2026 -1,937.24%
Dec 31, 2025 -1,559.17%
Sep 30, 2025 -1,519.59%
Jun 30, 2025 -1,351.89%
Mar 31, 2025 -1,112.51%
Dec 31, 2024 -1,098.78%
Sep 30, 2024 -822.83%
Jun 30, 2024 -706.82%
Mar 31, 2024 -604.98%
Dec 31, 2023 -585.69%
Sep 30, 2023 -645.78%
Jun 30, 2023 -732.68%
Mar 31, 2023 -916.52%
Dec 31, 2022 -1,173.46%
Sep 30, 2022 -1,717.17%
Jun 30, 2022 -2,947.52%
Mar 31, 2022 -8,093.89%
Dec 31, 2021 -131,392.86%
API Access

PMV Pharmaceuticals EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PMVP&period=max&api_key=YOUR_API_KEY